stroma

Can Targeting the Stroma be a Therapeutic Strategy?

Yes, targeting the stroma is an emerging therapeutic strategy in cancer treatment. By disrupting the supportive role of the stroma, it is possible to inhibit tumor growth and metastasis. Therapies targeting CAFs, ECM components, and stromal signaling pathways are currently under investigation and show promise in preclinical and clinical studies.

Frequently asked queries:

What is the Stroma?
How Does Stroma Influence Tumor Growth?
How Do Immune Cells in the Stroma Affect Cancer?
What is the Role of the Extracellular Matrix (ECM)?
How Does the Stroma Contribute to Metastasis?
Can Targeting the Stroma be a Therapeutic Strategy?
How Can Inventors Navigate the Patent Process?
How do Integrins Function in Normal Cells?
What are the Challenges in Read Depth Normalization?
How Can Patient Reviews Help in Choosing a Cancer Treatment Facility?
Why Are Gala Dinners Important for Cancer?
What are the Common Methods for Reducing Tumor Size?
How is Neutropenia Related to Cancer?
How Can Patients and Caregivers Manage Epilepsy in the Context of Cancer?
What Role Do Public Institutions Play in IP Management?
What are the challenges and limitations of these innovations?
Who Is Eligible for MRSG?
What Should Patients Expect During a Physical Exam?
What are the best foods to eat to reduce cancer risk?
Why are Treatment Effect Estimates Important?
Top Searches
Brain Tumor Breast cancer cancer Cancer Diagnostics Cancer Genomics Chemotherapy hepatocellular carcinoma Lung Cancer Nanotechnology Non-Hodgkin’s Lymphoma Radiation-Induced Malignancies
Follow Us

Partnered Content Networks

Relevant Topics